What is Phase Genomics?
Phase Genomics leverages proprietary proximity ligation technology to facilitate chromosome-scale genome assembly, metagenomic deconvolution, and the analysis of structural genomic variation and genome architecture. The Seattle-based company, founded in 2015, offers a comprehensive suite of laboratory and computational services, including Hi-C kits for diverse sample types and an industry-leading software platform for genome and metagenome assembly and analysis. Their mission is to equip scientists with genomic tools that accelerate breakthrough discoveries.
How much funding has Phase Genomics raised?
Phase Genomics has raised a total of $7.4M across 4 funding rounds:
Debt
$150K
Debt
$213K
Grant
$5.5M
Other Financing Round
$1.5M
Debt (2020): $150K with participation from PPP
Debt (2021): $213K led by PPP
Grant (2022): $5.5M supported by National Institute of Allergy and Infectious Diseases and Bill & Melinda Gates Foundation
Other Financing Round (2024): $1.5M featuring Bill & Melinda Gates Foundation
Key Investors in Phase Genomics
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation, established in 2000, is a global organization focused on improving health and reducing poverty, often supporting initiatives in scientific research and public health.
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is part of the NIH and focuses on research into infectious diseases, including the development of vaccines and therapeutics.
PPP
Public-Private Partnership
What's next for Phase Genomics?
The recent major strategic investment in Phase Genomics signals a pivotal growth phase for the company. This capital is likely to fuel further expansion of its technological capabilities, enhance its service offerings, and broaden its market reach within the biotechnology and research sectors. The company's focus on enabling complex genomic analyses positions it to capitalize on the increasing demand for high-resolution genomic data across various scientific disciplines, from human health to environmental studies.
See full Phase Genomics company page
